The Endometriotic Neoplasm Algorithm for Risk Assessment (e-NARA) Index Sheds Light on the Discrimination of Endometriosis-Associated Ovarian Cancer from Ovarian Endometrioma
article
OA: gold
CC0
⤵ 1 in-corpus citation
AI-generated summary
The e-NARA index, incorporating age, tumor diameter, and R2 value, accurately discriminates endometriosis-associated ovarian cancer from ovarian endometrioma.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Background: Magnetic resonance (MR) relaxometry provides a noninvasive tool to discriminate endometriosis-associated ovarian cancer (EAOC) from ovarian endometrioma (OE) with high accuracy. However, this method has a limitation in discriminating malignancy in clinical use because the R2 value depends on the device manufacturer and repeated imaging is unrealistic. The current study aimed to reassess the diagnostic accuracy of MR relaxometry and investigate a more powerful tool to distinguish EAOC from OE. Methods: This retrospective study was conducted at our institution from December, 2012, to May, 2022. A total of 150 patients were included in this study. Patients with benign ovarian tumors (n = 108) mainly received laparoscopic surgery, and cases with suspected malignancy (n = 42) underwent laparotomy. Information from a chart review of the patients’ medical records was collected. Results: A multiple regression analysis revealed that the age, the tumor diameter, and the R2 value were independent malignant predicting factors. The endometriotic neoplasm algorithm for risk assessment (e-NARA) index provided high accuracy (sensitivity, 85.7%; specificity, 87.0%) to discriminate EAOC from OE. Conclusions: The e-NARA index is a reliable tool to assess the probability of malignant transformation of endometrioma.
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (79)
- A diagnostic challenge of seromucinous borderline tumor via openalex
- A Novel Predictive Tool for Discriminating Endometriosis Associated Ovarian Cancer from Ovarian Endometrioma: The R2 Predictive Index via openalex
- Cancer Implications for Patients with Endometriosis via openalex
- Chronic Niche Inflammation in Endometriosis-Associated Infertility: Current Understanding and Future Therapeutic Strategies via openalex
- Chronic pelvic pain and endometriosis: translational evidence of the relationship and implications via openalex
- Clinical Management of Endometriosis via openalex
- Clinical Management of Endometriosis via openalex
- Computed diffusion-weighted imaging for differentiating decidualized endometrioma from ovarian cancer via openalex
- Cyst fluid iron-related compounds as useful markers to distinguish malignant transformation from benign endometriotic cysts via openalex
- Diagnosis and initial management of dysmenorrhea. via openalex
- Dysmenorrhea and Endometriosis: Diagnosis and Management in Adolescents via openalex
- Endometriosis via openalex
- Endometriosis and Infertility via openalex
- Endometriosis‐associated infertility: aspects of pathophysiological mechanisms and treatment options via openalex
- External Validation of the IOTA Classification in Women with Ovarian Masses Suspected to Be Endometrioma via openalex
- Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries via openalex
- Malignant Transformation of Pelvic Endometriosis: MR Imaging Findings and Pathologic Correlation via openalex
- Medical Treatments for Endometriosis-Associated Pelvic Pain via openalex
- MRI of Endometriotic Cysts in Association With Ovarian Carcinoma via openalex
- Peritoneal fluid biomarkers in patients with endometriosis: a cross-sectional study via openalex
- Quality of life in women with endometriosis: a cross-sectional survey via openalex
- Relationship of Benign Gynecologic Diseases to Subsequent Risk of Ovarian and Uterine Tumors via openalex
- Rethinking endometriosis and pelvic pain via openalex
- Risk and prognosis of ovarian cancer in women with endometriosis: a meta-analysis via openalex
- The Comparison of Three Predictive Indexes to Discriminate Malignant Ovarian Tumors from Benign Ovarian Endometrioma: The Characteristics and Efficacy via openalex
- The Impact of Endometriosis on Quality of Life in Adolescents via openalex
- The Origin and Pathogenesis of Endometriosis via openalex
- The social and psychological impact of endometriosis on women's lives: a critical narrative review via openalex
- Transverse Relaxation Rate of Cyst Fluid Can Predict Malignant Transformation of Ovarian Endometriosis via openalex
- W2835323295 via openalex
- W2904061041 via openalex
- W2911188335 via openalex
- W2922503148 via openalex
- W2968673361 via openalex
- W3028643075 via openalex
- W3031146420 via openalex
- W3032582302 via openalex
- W3045158392 via openalex
- W3092952440 via openalex
- W3101601947 via openalex
- W3104376072 via openalex
- W3114379926 via openalex
- W3138864307 via openalex
- W3165294846 via openalex
- W3173308520 via openalex
- W4206521692 via openalex
- W4211081176 via openalex
- W4281559122 via openalex
- W4283772796 via openalex
- W6603047530 via openalex
- W6675028185 via openalex
- W1777364357 via openalex
- W1895798608 via openalex
- W1961928411 via openalex
- W1967657836 via openalex
- W1972130358 via openalex
- W1980181125 via openalex
- W1982791756 via openalex
- W2004473068 via openalex
- W2005387633 via openalex
- W2030250649 via openalex
- W2033707203 via openalex
- W2042633087 via openalex
- W2059107101 via openalex
- W2061280013 via openalex
- W2069560633 via openalex
- W2070369494 via openalex
- W2077592267 via openalex
- W2079190330 via openalex
- W2099137273 via openalex
- W2102371025 via openalex
- W2118278569 via openalex
- W2134576998 via openalex
- W2138482047 via openalex
- W2305551225 via openalex
- W2438866487 via openalex
- W2500759354 via openalex
- W2515153451 via openalex
- W2807649309 via openalex
Cited by (1)
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-30T00:34:38.352865+00:00
License: CC0
· commercial use OK